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Abstract Respiratory syncytial virus (RSV) most often
causes severe respiratory disease in the very young and the
elderly. Acute disease can also cause exacerbations of asth-
ma in any age group. Recent findings provide insight into
how the innate and adaptive immune systems respond to
RSV infection and provide preliminary evidence that these
effects vary significantly by RSV strain and host. Compo-
nents of cell signaling pathways that induce inflammatory
cytokine expression during the innate immune response and
alter epithelial cell polarity through activating transcription
factors, namely NF-κB, are now more clearly understood.
New studies also reveal how RSV infection skews T helper
(Th) cell differentiation away from the cell-mediated Th1
subset and towards the Th2 subset. There are also new data
supporting preferential Th17 differentiation during RSV
infection. In addition, effective immune system regulation
of IL-10 expression and T regulatory cell (Treg) airway
accumulation are essential for effective RSV clearance.
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Introduction
Respiratory syncytial virus (RSV) is an enveloped negative
sense single-strand RNA virus of the Paramyxoviridae fam-
ily and pneumovirus genus. RSV infection is most common
in infants and young children: nearly all children are
infected by 2 years of age [1]. RSV infection of infants
can lead to serious respiratory disease, sometimes requiring
hospitalization. In a screen for viral and atypical bacterial
respiratory pathogens, RSV was the most prevalent patho-
gen (43.3 %) infecting children less than 5 years old with
acute respiratory infection (ARI), as well as extremely com-
mon agent (44.1 %) in co-infection cases of 2 or more
pathogens in the same cohort [2].
In conjunction, it has long been speculated that acute RSV
infection during infancy correlates with a greater risk of aller-
gic asthma later in life [3, 4]. This correlation is evident in a
longitudinal study by Sigurs and colleagues of 47 children
who were hospitalized with RSV lower respiratory tract in-
fection (LRTI) when they were less than 1 year old [5••]. In a
recent follow-up with the patients at age 18, the RSV LRTI
cohort had increased incidence of asthma with recurrent
wheeze, asthma without recurrent wheeze, and allergic rhino-
conjunctivitis (ARC) compared with 92 age-matched control
patients (Table 1) [5••]. In addition, the LRTI cohort had
increased sensitization to animal dander and perennial aller-
gens as well as decreased spirometric function [5••].
These and other epidemiological data support 2 notions.
RSV could have a long-lasting effect via an alteration of the
immune response; it is also possible that early RSV infection
serves as an indication of inherent differences in an individ-
ual’s immune system, which leaves it not only vulnerable to
serious RSV infection, but also to other, chronic respiratory
conditions (eg, recurrent wheeze and asthma). It is also
possible that these hypotheses work in combination.
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Many of the RSV studies have explored these broad hy-
potheses by examining the effects of RSVon different aspects
of the immune response in both human patients and mouse
models. Recent work has done a great deal to expound the
mechanisms underlying the immune response to RSV infec-
tion through investigating the formative signaling pathways
and genetic underpinnings to the subsequent differential cel-
lular responses. RSV infection causes a wide array of immu-
nologic responses; clarifying the ways in which RSV triggers
these changes may lead to the development of effective ther-
apeutics that can ameliorate or abolish acute and chronic
disease that result from ineffective immune system response.
Initial RSV Infection, Cell Signaling, and the Innate
Immune System Response
RSV predominantly infects primary airway epithelial cells,
but can also infect other structural airway and immune cells.
The host cells recognize RSV via toll-like receptors (TLRs).
RSV commonly activates TLR2, TLR3, and TLR4 [6–9]. In
addition, new research shows TLR7 activation during RSV
infection [10•]. These receptors in turn promote expression
and secretion of inflammatory cytokines (Table 2), which
mount the earlier innate immune response and subsequent
adaptive immune response. To elicit these responses, several
different signaling pathways and their respective molecules
are utilized. These include pathways that include protein
kinase C (PKC), mitogen-activated protein kinase (MAPK),
and nuclear factor-κB (NF-κB).
p38 MAPK and extracellular signal-regulated kinase
(ERK) MAPK are both involved in RSV replication in
human airway epithelial cells [11]. Pharmacologic inhibitors
for p38 and ERK (SB203580 and U0126, respectively) both
decreased viral replication when cells were treated
30 minutes prior to infection. In primary fibroblasts from
myeloid differentiation factor 88 (MyD88) knockout (KO)
mice, RSV-induced p38 activation was MyD88-dependent,
whereas ERK activation was MyD88-independent. In the
presence of anti-TLR4 antibodies, p38 MAPK activation
decreased, whereas ERK MAPK remained unchanged. In
addition, immunofluorescence confocal microscopy
revealed that TLR4 clustering at the point of contact be-
tween the virus and cell was related to p38 activation,
helping to elucidate the mechanism of viral entry [11].
Upon viral entry and activation of signaling complexes,
inflammatory cytokines and chemokines are expressed and
secreted. One important chemokine during this response is
IL-8, which, as a chemoattractant, recruits neutrophils to the
location of infection [12]. RSV induces IL-8 expression,
which is mediated by NF-κB and AP-1 [13]. In RSV-
infected A549 cells, co-transfection of a reporter luciferase
gene coupled to the IL-8 promoter, and a dominant negative
(DN) mutation revealed that either of the 2 IKKβ DNs used
significantly decreased IL-8 promoter activation. An IKKβ
inhibitor, NEMO binding domain (NBD) fusion peptide,
significantly decreased IL-8 secretion. Therefore, NF-κB
was activated through the canonical pathway. In addition,
RSV infection increased JNK kinase activity. Inhibition of
JNK significantly reduced transfected AP-1 reporter activi-
ty, while leaving NF-κB reporter activity unaffected [14••].
The regulation of JNK and IKKβ was also examined.
MEKK1 and TAK1 are serine/threonine kinases that acti-
vate both JNK and IKKs [15, 16]. When A549 cells were
infected with RSV, TAK1 was essential to both AP-1 and
NF-κB activation [14••]. Thus, RSV infection caused IL-
8 expression through NF-κB and AP-1 induction via the







Current asthma/RW** 39 % 9 %
Current asthma only** 33 % 7 %
Allergic rhinoconjunctivitis (ARC)* 43 % 17 %
Atopic dermatitis 11 % 9 %
Animal dander sensitization*
(Positive skin prick test)
33 % 11 %
Perennial allergen sensitization**
(Positive skin prick test)
41 % 14 %
Positive Phadiatop response* (Allergic
sensitization as defined by Phadiatop)
56 % 28 %
* P≤0.005; **P≤0.001
Table 2 Summary of cytokines and chemokines produced during RSV infection
Cytokine Source Effects
IFN-γ NK cells, CD4+ T cells, CD8+ T cells Increases NK activation, Th1 differentiation
IL-1β Macrophages Increases expression of cytokines mediated by NF-κB
IL-4 CD4+ T cells Increases Th2 differentiation, decreases Th1 differentiation
IL-8 Epithelial cells, Macrophages Neutrophil recruitment
IL-10 CD4+ T cells Inhibits expression of inflammatory cytokines, suppresses inflammatory response
IL-17A CD4+ T cells Increases Th17 differentiation, increases inflammatory cytokine production
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canonical and the JNK pathway, respectively, and TAK1
was an upstream regulator able to mediate both responses.
However, TAK1 depletion did not entirely abrogate NF-κB
activation and nuclear translocation. Thus, there are likely
other kinases that regulate IKK and NF-κB activation dur-
ing RSV infection [14••].
The canonical pathway is not the only recently reported
means of induction of NF-κB during RSV infection in
human airway epithelial cells. In addition, the importance
of a non-canonical pathway mediated by the virus-activated
kinase (VAK) complex (composed of TBK-1 and IKKε) is
also evident [17]. In RSV-infected 293 cells transfected with
IKKε DN, IL-8 promoter activity was significantly down-
regulated in comparison to control cells at 12 hours post-
infection. Using siRNA in A549 cells and mouse embryonic
fibroblasts from IKKε KO mice, IKKε was determined to
regulate NF-κB during RSV infection through p65 Ser536
phosphorylation [17]. Thus, there is evidence for 2 separate
pathways of NF-κB activation during RSV infection.
In a similar vein, RSV infection leads to IL-1β expres-
sion, which is an inflammatory cytokine critical to antiviral
immune response. IL-1β works in an autocrine and para-
crine fashion, and ultimately causes the expression of a
number of NF-κB-dependent cytokines and chemokines
[18]. Mature IL-1β is produced and secreted by activated
macrophages following assembly and activation of inflam-
masomes in the cytoplasm [19, 20•]. This is achieved
through 2 signals: first, stimulation of a pattern recognition
receptor ensures expression of pro-IL-1β (the IL-1β precur-
sor) and inflammasome components; second, the inflamma-
some complex assembly and caspase-1 activation cleave
pro-IL-1β into IL-1β. This second signal is either initiated
by reactive oxygen species (ROS), cellular potassium efflux,
or cathepsin leakage into the cytosol after lysomal disinte-
gration. NF-κB activation through a TLR2/MyD88-depen-
dent pathway is necessary for the first signal of IL-1β
production in macrophages during RSV infection. The sec-
ond signal is a combination of ROS production and potas-
sium efflux via an ATP-sensitive potassium channel [20•].
These new findings elucidate the basic mechanism of IL-1β
production in RSV-infected macrophages.
Likewise, RSV induces IL-15 expression in both ep-
ithelial cell lines and primary bronchial epithelial cells.
IL-15 is produced by the canonical pathway induction
of NF-κB [21]. IL-15 is an inflammatory cytokine that
is suggested to augment antiviral defense through up-
regulation of IFN-related transcription factors, NF-κB,
synthesis of type 1 effector molecules, and survival and
stimulation of NK cells and CD8+ T cells [22–24].
Thus, effective expression of IL-15 could be beneficial
to effective RSV clearance; further research is required
to determine the importance of IL-15 in shaping the
immune response to RSV infection.
In addition to regulating inflammatory cytokine produc-
tion, NF-κB activation is associated with tight junction
formation in RSV-infected human nasal epithelial cells.
Tight junctions are important for epithelial cell polarity
and maintenance of tissue integrity. During RSV infection,
genes for tight junction molecules, claudin-2, -4, -7, -9, -14,
-19; occludin; ZO-2; cingulin and MAG-1 were up-
regulated at least 2-fold. NF-κB signaling through PKCδ
up-regulated claudin-4 expression [25]. Interestingly, inhi-
bition of NF-κB and PKCδ led to decreased viral replication
and decreased formation of virus filaments. This, along with
immunocytochemistry of tight junction proteins and viral
proteins (RSV proteins F and G) seem to suggest that
virally-induced tight junction formation could augment cell
polarity during RSV infection allowing for characteristic
viral budding at the apical surface [25].
Adaptive Immune System Response
RSV infection also leads to a specific adaptive immune re-
sponse. The characteristics of the adaptive immune response
(ie, which T helper cell subset and associated cytokines domi-
nate the response [Table 2]) can help to understand acute RSV
disease and the implication ofRSVinfection for potential long-
term respiratory disease. For instance, allergic asthma is char-
acterized by a Th2-mediated response [26]. Therefore, it is
important to realize any effects RSVinfection has on predispo-
sition to a certain adaptive immune response and the mecha-
nismbywhich itoccurs.RSVinfectionhasbeenassociatedwith
skewing the immune system away from an anti-viral Th1 re-
sponseand towardsaTh2response.Newdata shedlightonhow
this occurs and introduced a role of IL-17A (the principle
cytokine of Th17 response) in RSV infection as well, as anti-
body blockade of IL-17A led to significant reduction of viral
protein mRNA expression in the lungs and Th2 cytokine pro-
tein expression in the lymph nodes in RSV-infectedmice com-
pared with mice treated with control antibody [27]. This is
interesting because IL-17A has recently been implicated in
the development of severe forms of asthma [28].
Epithelial cells, in addition to providing a link to the initial
innate immune response, aid in adaptive immune system
activation after RSV infection. When human bronchial epi-
thelial cells (HBECs) were co-cultured with peripheral blood
mononuclear cells (PBMCs), there was an induction of IFN-γ,
IL-4, and IL-17 cytokine production, which suggested activa-
tion of lymphocytes as these are the characteristic cytokines of
T helper cell subsets Th1, Th2, and Th17, respectively [29].
When isolated lymphocytes were exposed to the supernatant
of RSV-infected HBECs, flow cytometry revealed that com-
pared with controls exposed to complete cell culture medium,
Th2 and Th17 differentiation was significantly induced, while
Treg differentiation was clearly suppressed [29]. In addition to
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inherent major histocompatibility complex (MHC) I, epitheli-
al cells may be able to express MHC II in times of stress or
disease, as well as costimulatory molecules CD80 and CD86
during infection [30–32]. Therefore, it is conceivable that
HBECs directly activate naïve CD4+ lymphocytes during
RSV infection.
Epithelial cells could also activate lymphocytes by an
indirect means. RSV infection of primary rat airway epithe-
lial cells (PRAECs) caused upregulated thymic stromal
lymphopoietin (TSLP) 6 to 18 hours post-infection [33].
When RSV-infected PRAECs were cocultured with myeloid
dendritic cells (mDCs), the mDCs had increased major
histocompatibility complex II (MHC II) and CD86, but not
CD80 expression. In the same coculture system, siRNA for
TSLP effectively decreased TSLP expression and also the
expression of MHC II and CD86, without changing CD80
expression. In this mDC- and RSV-infected PRAEC cocul-
ture system, mDCs also up-regulated mRNA expression of
molecules important for Th2 polarization: thymus- and
activation-regulation chemokine (TARC) and OX40L, while
TNF-α mRNA was down-regulated. Functional mDC mat-
uration was verified, as mDCs exposed to RSV-infected
PRAECs significantly increased T cell proliferation in com-
parison to uninfected PRAECs [33]. Thus, it is possible that
RSV infection of epithelial cells leads to a differential T
helper cell response through the polarization of mDCs, and
potentially directly through epithelial cell antigen presenta-
tion. However, this study did not assess the ability of affect-
ed mDCs to alter naïve T cell differentiation. Further study
is necessary to further elucidate the mechanisms of T cell
activation and differentiation during RSV infection.
During RSV infection, natural killer (NK) cells may also
have a role in T cell differentiation [34]. Interestingly, past
clinical studies show that increased NK deficiency is linked to
increased respiratory disease symptoms. Specifically, NK cell
numbers were reduced in hospitalized bronchiolitis cases, and
ventilated infants exhibited an even greater (3-fold) reduction
in NK cells. In fatal RSV bronchiolitis cases, patients were
nearly devoid of NK cells [35–37]. In BALB/c mice,
antibody-mediated NK cell reduction during RSV infection
resulted in lower IFN-γ production and an increase in Th2
cytokines. This result was dependent on IL-25 produced by
airway epithelial cells: IL-25 up-regulated Jagged1 on den-
dritic cells and led to increased Th2 differentiation [34].
Immune System Regulation During RSV Infection
Just as the immune system needs to effectively activate and
clear a pathogen, it also needs an effective system of self-
regulation and inhibition to inhibit an unbalanced immune
response and collateral damage of host tissue. Studies ex-
amining humans and mouse models reveal that inefficient
immune system regulation escalates respiratory disease pa-
thology following RSV infection, and can also lead to less
optimal viral clearance.
IL-10 is an extremely important regulatory cytokine. It
mediates suppression of the activation and effector functions
of many immune system cells. As can be expected, it is
important in RSV infection and resultant disease pathogen-
esis. In hospitalized infants with RSV bronchiolitis, IL-10
concentration in nasopharyngeal aspirates were significantly
higher in infants who later developed post-bronchiolitis
wheeze (PBW) than in those who did not [38]. However,
this difference in IL-10 concentration was not correlated to
the rs1800872 single-nucleotide polymorphism (SNP) in the
IL10 promoter region. This SNP was considered because
heterozygous expression was previously correlated with
protection from RSV bronchiolitis [39, 40]. So, although
there is some support for a protective role from this IL10
genetic variation, the potential functional role during RSV
infection remains unclear [38].
That said, it is also possible that during RSV infection the
IL-10 response is modulated via indirect genetic factors. For
instance, IL-19 and IL-20 are both IL-10 family cytokines
and their genes are clustered with IL10 (as well as IL24)
[41–43]. In 1 recent study of 166 hospitalized infants with
RSV LRTI, 1 SNPs of the IL19 gene (rs2243191 and
rs2243188) and 1 SNP of IL20 gene (rs2981573) were
associated with protection from recurrent wheeze (OR 0.4,
0.5, and 0.4, respectively). From these SNPs, 3 haplotypes
comprised 99 % of all the IL19/IL20 haplotypes in the
patients. Only 1 of these haplotypes, TGG (the nucleotides
of rs2243191, rs2981572, and rs2981573, respectively), was
significantly related to recurrent wheeze after LTRI. It had a
protective role, with an odds ratio of 0.43 [44]. Perhaps
changes in IL-10 family cytokine expression through SNPs
play a role in direct immune system regulation during RSV
infection. It is also possible that their expression influences
IL-10 expression during infection because IL-10 family
members cross-regulate each other in other models [44, 45].
These cohort studies show that IL-10 has some in-
fluence in disease pathogenesis, prompting studies to
focus on elucidating the mechanism of IL-10 and other
factors of immunosuppression during RSV infection in
mouse models. CD4+ and CD8+ T cells both produced
IL-10 in the lung during RSV infection in mice, with
production peaking at 8 days post infection [46•]. The
majority of IL-10 producing T cells were CD4+ during
RSV infection. The vast majority of CD8+ T cells that
produce IL-10 co-produced IFN-γ, while this was less
true for CD4+ T cells [47]. However, CD8+ cells also
may have modulated IL-10 production, as depletion of
CD8+ cells led to a significant increase in IL-10. Thus,
these data support that CD8+ cells play a suppressive
role in CD4+ IL-10 production [46•].
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Although CD4+ T cells are the major producers of IL-10
in mouse RSV infection, the subset that contributes most to
this production is not as clear. One group has shown T
regulatory cells (CD4+Foxp3+) was the most common IL-
10 expressing cells in the lung, mediastinal lymph node
(MLN) and BAL fluid of infected mice, while another has
shown that CD4+Foxp3- are the majority of IL-10 express-
ers [46•, 47]. Thus, it needs to be determined under which
circumstances, if any, each subset expresses the most IL-10.
In IL-10 KO mice and WT mice treated with anti-IL-10R
antibody, RSV infection increased disease and delayed re-
covery when compared to IL-10 producing and control
antibody treated mice, respectively [46•, 47]. IL-10 deple-
tion was associated with increased weight loss, airway ob-
struction, edema, tissue inflammation, and mucus
production. These macroscopic changes were marked by a
congruous increase in inflammatory cytokines (IL-6, IL-
17A, IL-17F, IFN-y, TNF-a) and chemokines (CXCL1,
CXCL10, CXCL9, CCL1, CCL2, CCL3) [46•, 47–49].
Thus, a lack of IL-10 resulted in an altered adaptive immune
response, providing evidence that IL-10 is an important
regulator of inflammation during RSV infection. This is
reflected at the cellular level: with IL-10 depletion there
was a decrease in total cell recruitment to the BAL at day
4, whereas there was increased airway inflammation 6 and
8 days post-infection [47, 49]. This trend could be respon-
sible for the lag in viral clearance in comparison to control
mice. In addition, there was a decrease in natural T regula-
tory cells (CD4+Foxp3+Helios+) when mice were given
anti-IL-10R antibody [46•].
As IL-10 is an important regulatory cytokine, T regulatory
cells (Tregs; CD4+Foxp3+) are responsible for suppressing the
adaptive immune response. They are, therefore, instrumental
to effective host response to RSV infection. After RSV infec-
tion in mice, there was a rapid accumulation of Tregs in the
airways and secondary lymphoid tissue. By 4 days post-
infection there is a 50-fold increase in Tregs in the BAL fluid
of infected mice compared to naïve mice. This drastic increase
was amplified 8 days post-infection to an 86-fold increase
over naïve mice. There was also significant Treg accumulation
observed in the lung parenchyma and MLNs and a slight
increase in the spleen [50].
Local proliferation of Tregs occurred with 78 % and 69 %
of Tregs expressing the proliferation marker Ki-67 in the BAL
and lung parenchyma, respectively, 6 days post-infection [50].
In addition, the majority of Tregs expressed activation
markers, which were up-regulated post-infection. CD43glyco,
ICOS, CTLA-4, CD69, OX40, and PDL-1 were all signifi-
cantly increased 6 days post-infection. CD25+ Tregs present in
the airways increased significantly as well. With the clearance
of RSV, the number of Tregs decreased, returning to baseline
numbers. Treg efflux took longer in the BAL and MLNs than
in the lung parenchyma and spleen [50].
Tregs are important in the immune response to RSV
infection. A 60 % decrease in CD4+Foxp3+CD25+ Tregs
using CD25-neutralizing antibodies was extremely detri-
mental to immune system efficiency, leading to a significant
increase in time of viral clearance. This delay could be
traced to a delay in the recruitment in RSV-specific CD8+
T cells to the lung [50]. This finding argues that Tregs are
more than just immunosuppressors; they also act as con-
ductors of an effective immune response for RSV clearance.
Different Strains, Different Cells: Different Response
As can be surmised in understanding the vast and intricate
effects of RSV infection on the immune system response, it is
important to acknowledge that there is variability of immune
response to RSV infection from case to case. There are many
different strains of RSV that each contains significant genetic
variability, leading to altered virulence and subsequent disease
pathogenesis. Also, the characteristics of the infected host cell
(ie, species and type of cell) can lead to differential cellular
and systematic responses. This is especially important to keep
in mind in examining in vitro studies that focus on a small
number of cell types. Obviously, it is necessary to use basic
systems to garner mechanistic understanding, but we must be
mindful of the plasticity inherent in these mechanisms and
their phenotypic manifestations. Inherent differences lead to
differences in the innate and adaptive immune responses
triggered by RSV infection.
Several recently published studies examine the effects of
intrinsic differences on RSV pathogenesis and immune re-
sponse. In examination of the pathogenesis of several RSV
isolates in a BALB/cJ mouse model, both laboratory strains
(A2, Long, and line19) and clinical strains (A2001/2-20,
A2001/3-12, A1997/12-35, A2000/3-4, A1998/3-2, and
A1998/12-21) were studied [51•]. Of the laboratory strains,
only A2 caused host weight loss, while 3 of 6 clinical isolates
(3–12, 2–20, 12–35) caused weight loss post-infection. While
those 4 isolates caused weight loss, they all caused different
patterns of weight loss: early, late, and bimodal patterns were
all represented. Similarly, strains caused differing character-
istics and disease phenotypes including: varying expression of
lung IL-13 and gob-5 protein, amount of in vitro replication,
in vivo viral load, and other characteristics. Fundamental
differences in immune response followed these variations in
the observable effects of disease. Indeed, in a comparison of
A2, 2–20, 3–12, and line 19 at 8 days post-infection, A2
infection had a significantly greater amount of CD8+ T cells
in the lung that produced IFN-γ than 2–20 and line 19.
Interestingly, this matched PAS staining data that showed
A2 as nonmucogenic, whereas 2–20 and line 19 were muco-
genic. This finding links the role of T cell differentiation and
disease pathogenesis [51•].
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A similar study examined a variety of RSV strains (A2 and
3 clinical isolates: BT2a, BT3a, BT4a) in primary human
bronchial epithelial cells (PBECs) from healthy children
[52]. As in the aforementioned mouse model, the strains were
characterized by different patterns of infection. The strains
differed drastically in their ability to infect PBECs, as revealed
by host cell expression of viral F protein. A2 was much more
infectious; at 72 hours post-infection, most host cells were
infected. In contrast, the clinical isolates were not nearly as
infectious, and displayed differential infectivity (BT2a was
most infectious, BT4a was least). This difference carried over
to viral growth kinetics: A2 grew more quickly and to higher
titers than the clinical isolates. A2 titers reached 5.25 log10
TCID50/mL at anMOI 0.1, whereas the clinical isolates BT2a,
BT3a, and BT4a reached 4.20, 3.80, 3.25 log10 TCID50/mL,
respectively. Interestingly, all strains initiated a post-infection
increase in the concentration of the chemokines and cytokines
RANTES, IP-10, IL-6, and IL-8 in supernatants. However, by
72 hours post-infection, A2 had significantly higher concen-
trations of IP-10 and RANTES than the mock infections and
clinical isolates. Similarly, IL-8 was significantly up-regulated
by only A2 and BT4a and IL-6 only by BT4a [52]. So,
inflammatory chemokine and cytokine release varied by
RSV strain, which would likely elicit a variable immune
system response in an in vivo model.
From the opposite perspective, the types of cells used for
experimental infection are also important. For instance, a
group examined RSV infection in airway epithelial cells
(AECs) from lungs of healthy children and cells of the
BEAS-2B cell line [53•]. They determined that the peak of
RSV replication (as determined by real-time PCR for RSV N-
gene expression) was 2 to 3 log-fold greater in AEC cultures
than in BEAS-2B cultures. Similarly, cytotoxicity was greater
in AECs. Although both cell culture supernatants contained
high concentrations (>500 pg/mL) of IL-8 and IL-6 from 3 to
48 hours post-infection, AECs had significantly greater con-
centrations of IL-8 than BEAS-2B from 6 to 24 hours post-
infection [53•]. In short, the response to RSV infection dif-
fered between epithelial cells derived from epithelial cell lines
and from the lungs of children.
Conclusions
Recent advancements in RSV research have illuminated the
signal transduction pathways that are activated to initiate
transcription of inflammatory cytokines and chemokines once
RSV is recognized by a TLR on the cell surface. In addition,
Th2 and Th17 differentiation and role in disease progression
during RSV infection are better understood. That said, it is
necessary to better characterize the link between the innate
and adaptive immune systems post-infection, and how varia-
tions in this link can lead to variations in acute and chronic
airway disease. Understanding the influence of regulatory
agents (eg, IL-10, Tregs) host genetic predisposition, viral
strain, and other factors on this combined immune response
may help glean new therapeutic avenues.
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